Atai Life Sciences Total Liabilities 2020-2025 | ATAI

Atai Life Sciences total liabilities from 2020 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Atai Life Sciences Annual Total Liabilities
(Millions of US $)
2024 $43
2023 $49
2022 $40
2021 $28
2020 $16
2019 $2
Atai Life Sciences Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $44
2024-12-31 $43
2024-09-30 $51
2024-06-30 $47
2024-03-31 $46
2023-12-31 $49
2023-09-30 $40
2023-06-30 $38
2023-03-31 $40
2022-12-31 $40
2022-09-30 $47
2022-06-30 $29
2022-03-31 $29
2021-12-31 $28
2021-09-30 $21
2021-06-30 $21
2021-03-31 $25
2020-12-31 $16
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $2
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.445B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.977B 19.69
Encompass Health (EHC) United States $12.014B 25.47
DaVita (DVA) United States $10.307B 14.49
Chemed (CHE) United States $8.041B 25.27
Elanco Animal Health (ELAN) United States $6.759B 14.48
Option Care Health (OPCH) United States $5.214B 23.24
RadNet (RDNT) United States $4.244B 269.33
Amedisys (AMED) United States $3.200B 21.52
Addus HomeCare (ADUS) United States $2.098B 23.04
LifeStance Health (LFST) United States $1.960B 0.00
Astrana Health (ASTH) United States $1.382B 34.25
U.S Physical Therapy (USPH) United States $1.131B 29.20
Pennant (PNTG) United States $0.961B 35.28
Aveanna Healthcare Holdings (AVAH) United States $0.942B 53.67
Daxor (DXR) United States $0.044B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.043B 0.00
Ontrak (OTRK) United States $0.006B 0.00
Psychemedics (PMD) United States $0.000B 0.00